News & Updates

Tirzepatide appears to yield substantially greater reductions in weight than semaglutide in the real-world treatment of overweight or obesity in adults with or without diabetes, according to a study.

Poor glycaemic control in patients with type 1 (T1D) or type 2 diabetes (T2D) contributes to a faster estimated glomerular filtration rate (eGFR) decline following diabetic kidney disease (DKD) onset, suggests a study. This association is more pronounced among those with severe albuminuria.

Use of rosuvastatin is associated with a significantly lower decline in left ventricular ejection fraction (LVEF) and lower serum levels of cardiotoxicity-associated biomarkers in newly diagnosed HER2-positive breast cancer patients treated with anthracycline-based chemotherapy followed by trastuzumab, according to the results of a prospective, randomized, controlled, parallel study.